Medical regulators approve a gene therapy that aims to cure sickle cell disease and beta thalassemia.
Source link
Casgevy: UK approves gene-editing drug for blood disorders
RELATED ARTICLES
Medical regulators approve a gene therapy that aims to cure sickle cell disease and beta thalassemia.
Source link